Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

Hims & Hers' lower-priced injectable semaglutide promoted during the Super Bowl has led to some patients receiving the more ...

Drinking artificially sweetened beverages may reduce metformin’s effectiveness in young patients with obesity and prediabetes ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing mobile clinical network ...

While one study found lower rates of preterm birth alongside higher rates of hypertensive disorders, another found fewer ...

Finally, a study of 154 people on metformin for weight loss found that participants lost an average of 5.6 to 7 kg (that’s ...

Metformin. Metformin is an oral diabetes medication that ... of 30 or more and without diabetes studied semaglutide vs a ...

Spending on older medicines like metformin, used only for diabetes, declined. But that of popular GLP-1 drugs such as Novo ...

The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...

On the way to lead him to see Emperor Zhaode. so as to save the mother. In recent years, semaglutide pills have emerged as a hopeful option for people struggling with obesity.s distressed look.